Tag Archive for: Cytovation

Mode of action of CY-101Cytovation ASA
Financing

Cytovation ASA bags additional US$6m to drive Phase II study

Cytovation ASA has baged US$6m to advance Phase II development of its bi-specific pore-forming peptide candidate CY-101 in patients with adrenocortical carcinoma.

Read more
Multiple factors determine whether tumor cells will be eliminated by the immune system or will escape detection.© wikimedia.com/By Frontiers in Oncology - http://www.frontiersin.org/files/Articles/51138/fonc-03-00197-HTML/image_m/fonc-03-00197-g001.jpg, CC BY 3.0, https://commons.wikimedia.org/w/index.php?curid=33585764
financing

Cytovation ASA raises US$8m in Series A

Bergen-based Cytovation ASA has raised US$8m in a Series A extension round to push its cancer compound CyPep-1 into Phase II clinical testing.

,

Read more